Podcast | March 24, 2026

Rx for Biotech Podcast: “The Future of Precision Medicine & How Biomarkers Can Guide Treatment”

“There isn’t a single purpose for a biomarker. A biomarker is simply a measurement that carries biological meaning. Depending on the context, it can help detect disease early, predict how severe an illness may become, distinguish which patients have different underlying drivers of the same condition, or guide the choice of the most appropriate therapy. Biomarkers in precision medicine can also be used to monitor whether a treatment is working as intended or to determine whether a disease has returned.

This entire framework reflects a broader truth: biology is dynamic and far more complex than the simple, linear model many of us learned in school. Rather than moving neatly from DNA to RNA to protein to function, every step is shaped by layers of regulation and variation. Historically, we’ve had to rely on indirect measurements or assumptions about these layers because our tools couldn’t capture that complexity directly. But as technologies improve, we’re increasingly able to measure more of the biological features that truly matter, rather than inferring them from upstream signals.

When researchers and biopharma organizations can access rich, well‑characterized data – especially data collected over time rather than at a single point – they gain a clearer understanding of how disease emerges, evolves, and responds to treatment. This shift makes it possible to identify which biological markers genuinely differentiate one patient’s disease from another’s, determine who is most likely to benefit from a given therapy, and generate insights that support more tailored, precise interventions. In other words, the more directly and dynamically we can observe human biology, the more effectively we can diagnose, treat, and monitor disease.”

This excerpt is just part of the Rx for Biotech podcast’s full episode discussion featuring Sapient’s Founder and CSO, Dr. Mo Jain, tackling varied topics that are shaping the future of biomarkers in precision medicine.

Dr. Jain and host Chris Leidli touch on a number of trends and innovations that are driving the next generation of AI-enabled biological insights and how they are impacting the efficiency and success rates of therapeutic development. Together, they explore:

  • How AI and data science are accelerating not just biomarker and target discovery, but validation for effective translation
  • Why metabolomics and multi-omics are becoming critical tools in precision medicine
  • How biomarker-guided drug development can improve clinical trial success rates
  • What the future of AI-powered medicine could look like

Listen above or search “Rx for Biotech” on your favorite podcast platform!

Follow Us